Aridor says the treatment will be effective immediately, last only a few weeks, have no or minimal side-effects and be available at a much lower cost than other options.
"We made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer", Dr. Ilan Morad, AEBi CEO, told the news outlet.
In many ways, this sounds too good to be true, not least because cancer is the second leading cause of death worldwide.
The Israeli scientists studied why previous cancer drugs failed.
"The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used", Morad continued. "Instead of attacking the receivers one at a time, we attack the receivers three at a time; even cancer can not mutate three receptors at the same time". "Our solution will be both generic and personal".
Woman with baby dies after falling down NYC subway stairs
At the time , she had been trying to carry her 1-year-old daughter's stroller down the steps to a southbound train. It's unclear if the fall was accidental or if some sort of medical condition contributed to Goodson's fall.
Trump Campaign Threatens Former Staffer With NDA Lawsuit
In a tweet Tuesday, the president said Cliff Simms was a "low level staffer" that he hardly knew. Trump has reportedly been pissed off about the book but up until Tuesday morning held his tongue.
AL MVP Betts says he won't visit White House with Red Sox
American League MVP Mookie Betts , of the Boston Red Sox, will not attend the White House with his teammates. The Red Sox are now scheduled to visit on May 9 , per the Chicago Sun-Times.
He added: "My colleagues here at American Cancer Society tell me phage or peptide display techniques, while very powerful research tools for selecting high affinity binders, have had a hard road as potential drugs".
Another reason why cancer drugs fail and the disease returns is because the drugs do not destroy cancer stem cells.
It's not clear how the company could promise to offer a cancer cure within 12 months if clinical trials will take years.
The drug has not yet reached human trials, but the scientists say preclinical trials in mice have shown promising results.
Morad equated the concept of MuTaTo to the drug cocktail that has helped transform AIDS from being an automatic death sentence to a chronic yet manageable disease, according to the Israeli news outlet.
The experts even claimed the drug's side effects will be next to nothing, especially when compared to traditional cancer treatments like chemotherapy and radiotherapy.